Absorption Pharmaceuticals
Huntington Beach
About Absorption Pharmaceuticals
Absorption Pharmaceuticals (AP), LLC., founded in 2008 and based in Newport Beach, CA, is the manufacturer of PROMESCENT. The FDA approved treatment under strict monograph guidelines was developed by Dr. Ronald Gilbert, Urologist, Founder and Chief Medical Officer of Absorption Pharmaceuticals. The lidocaine based topical anesthetic utilizes a patented, advanced, transcutaneous absorption technology. Since PROMESCENT’S formal introduction in 2011, it has been enthusiastically embraced by leading experts in the field of sexual medicine and practicing urologists globally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Last round: Series Unknown (Feb 2014)
- Website: promescent.com
- Phone: (919) 414-6128
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/absorption-pharmaceuticals-2235937 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.